These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 34029640)

  • 1. Positive effects of Lianhuaqingwen granules in COVID-19 patients: A retrospective study of 248 cases.
    Shen P; Li J; Tu S; Wu Y; Peng Y; Chen G; Chen C
    J Ethnopharmacol; 2021 Oct; 278():114220. PubMed ID: 34029640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lianhuaqingwen capsule inhibits influenza-induced bacterial adhesion to respiratory epithelial cells through down-regulation of cell adhesion molecules.
    Du Q; Huang W; Zhao J; Zeng J; Zhang W; Huang X; Chen R; Jiang H; Xie Y; Wang Y; Zhong N; Wang X; Yang Z
    J Ethnopharmacol; 2021 Nov; 280():114128. PubMed ID: 33872750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lianhua Qingwen prescription for Coronavirus disease 2019 (COVID-19) treatment: Advances and prospects.
    Li LC; Zhang ZH; Zhou WC; Chen J; Jin HQ; Fang HM; Chen Q; Jin YC; Qu J; Kan LD
    Biomed Pharmacother; 2020 Oct; 130():110641. PubMed ID: 34321172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of combined therapy of qingfeiPaidu capsule and lianhuaqingwen capsule nursing interventions for hospitalized patients with COVID-19: A retrospective study of medical records.
    Li Y; Yu W; Zhai J; Wang K; Huo H; Du Z
    Medicine (Baltimore); 2022 Aug; 101(32):e29964. PubMed ID: 35960047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of lianhuaqingwen granules in the management of chronic rhinosinusitis without nasal polyps.
    Lin L; Dai F; Ren G; Wei J; Chen Z; Tang X
    Am J Otolaryngol; 2020; 41(1):102311. PubMed ID: 31732300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Lianhuaqingwen Capsules in adults with mild-to-moderate coronavirus disease 2019: an international, multicenter, double-blind, randomized controlled trial.
    Zheng JP; Ling Y; Jiang LS; Mootsikapun P; Lu HZ; Chayakulkeeree M; Zhang LX; Arttawejkul P; Hu FY; Truong TNL; Perez RA; Gu X; Sun HM; Jiang JJ; Liu RJ; Ding Z; Zhan YQ; Yang ZF; Guan WJ; Zhong NS
    Virol J; 2023 Nov; 20(1):277. PubMed ID: 38017515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A network pharmacology based approach for predicting active ingredients and potential mechanism of Lianhuaqingwen capsule in treating COVID-19.
    Zhang X; Gao R; Zhou Z; Tang X; Lin J; Wang L; Zhou X; Shen T
    Int J Med Sci; 2021; 18(8):1866-1876. PubMed ID: 33746604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New tale on LianHuaQingWen: IL6R/IL6/IL6ST complex is a potential target for COVID-19 treatment.
    Tianyu Z; Xiaoli C; Yaru W; Min Z; Fengli Y; Kan H; Li C; Jing L
    Aging (Albany NY); 2021 Nov; 13(21):23913-23935. PubMed ID: 34731090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Early Combination Therapy With Lianhuaqingwen and Arbidol in Moderate and Severe COVID-19 Patients: A Retrospective Cohort Study.
    Fang J; Li H; Du W; Yu P; Guan YY; Ma SY; Liu D; Chen W; Shi GC; Bian XL
    Front Pharmacol; 2020; 11():560209. PubMed ID: 33071781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Lianhua Qingwen on viral shedding in omicron mild/asymtomatic patients: a real-world study.
    Gai X; Yan C; Wu C; Duan Z; Fan J; Yuan S; Yang P; Bao F; Jing H; Cai C; Ma Y; Zhang W; Sun Y
    Front Med (Lausanne); 2024; 11():1357299. PubMed ID: 38596791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential effect of Maxing Shigan decoction against coronavirus disease 2019 (COVID-19) revealed by network pharmacology and experimental verification.
    Li Y; Chu F; Li P; Johnson N; Li T; Wang Y; An R; Wu D; Chen J; Su Z; Gu X; Ding X
    J Ethnopharmacol; 2021 May; 271():113854. PubMed ID: 33513419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of Reduqing granules in the treatment of common cold with wind-heat syndrome: a randomized, double-blind, double-dummy, positive-controlled trial.
    Ma Y; Zhang Z; Wei L; He S; Deng X; Ji A; Zhou B; Jiang D; Li M; Wang Y
    J Tradit Chin Med; 2017 Apr; 37(2):185-92. PubMed ID: 29960290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying potential anti-COVID-19 pharmacological components of traditional Chinese medicine Lianhuaqingwen capsule based on human exposure and ACE2 biochromatography screening.
    Chen X; Wu Y; Chen C; Gu Y; Zhu C; Wang S; Chen J; Zhang L; Lv L; Zhang G; Yuan Y; Chai Y; Zhu M; Wu C
    Acta Pharm Sin B; 2021 Jan; 11(1):222-236. PubMed ID: 33072499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective study of Pupingqinghua prescription versus Lianhuaqingwen in Chinese participants infected with SARS-CoV-2 Omicron variants.
    Dong Y; Zhai W; Fang B; Liu C; Yuan S; Wang Y; Song Q; Li H; Chen B; Cui D; Wang J; Wu Q; Zhou C; Zhou M; Li S; Zhuang X; Xu Q; Zheng Y; Wu Y; Zheng J; Cao M
    Front Pharmacol; 2022; 13():988524. PubMed ID: 36278166
    [No Abstract]   [Full Text] [Related]  

  • 15. Traditional Chinese Medicine Formulation Therapy in the Treatment of Coronavirus Disease 2019 (COVID-19).
    Shi J; Lu Y; Zhang Y; Xia L; Ye C; Lü Y; Chen S; Xu Q; Tang B; Yin K; Zhang J; Chen X; Yang Z
    Am J Chin Med; 2020; 48(7):1523-1538. PubMed ID: 33148005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features and the traditional Chinese medicine therapeutic characteristics of 293 COVID-19 inpatient cases.
    Shu Z; Zhou Y; Chang K; Liu J; Min X; Zhang Q; Sun J; Xiong Y; Zou Q; Zheng Q; Ji J; Poon J; Liu B; Zhou X; Li X
    Front Med; 2020 Dec; 14(6):760-775. PubMed ID: 32926319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Traditional Chinese Medicine (TCM) in the treatment of COVID-19 and other viral infections: Efficacies and mechanisms.
    Huang K; Zhang P; Zhang Z; Youn JY; Wang C; Zhang H; Cai H
    Pharmacol Ther; 2021 Sep; 225():107843. PubMed ID: 33811957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Traditional Chinese Medicine, Maxingshigan-Weijing in the management of COVID-19 patients with severe acute respiratory syndrome: A structured summary of a study protocol for a randomized controlled trial.
    Zeng C; Yuan Z; Pan X; Zhang J; Zhu J; Zhou F; Shan Z; Yuan Y; Ye R; Cheng J
    Trials; 2020 Dec; 21(1):1029. PubMed ID: 33357239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Lianhua Qingwen for children with SARS-CoV-2 Omicron infection: A propensity score-matched retrospective cohort study.
    Xu X; Wu H; Jin G; Huang J; Li J; Zhou J; Cao M; Sun D; Zhang W; Peng W; Pu Y; Chen C; Sun Y; Yang H; Zhou S; Fang B
    Phytomedicine; 2023 Mar; 111():154665. PubMed ID: 36641977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrating Chinese and western medicine for COVID-19: A living evidence-based guideline (version 1).
    Ge L; Zhu H; Wang Q; Li M; Cai J; Chen Y; Chen Y; Ding B; Fang B; Fei Y; Feng J; Guo X; Jiang R; Jiang Y; Li G; Li X; Li X; Liang Q; Liu J; Liu J; Liu Q; Liu S; Lu Y; Miao Q; Qi W; Shang H; Shi L; Tan X; Tang X; Wang X; Wang X; Xia W; Yang K; Yang L; Ye Y; Zhou Q; Zhang H; Zhang J; Zhang Z; Zhang Z; Zou X; Li J; Wu D
    J Evid Based Med; 2021 Dec; 14(4):313-332. PubMed ID: 34632732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.